Gene · 8742
Papers2,943
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,943
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomic Profiling of Early Secreted Proteins in Response to Lipopolysaccharide-Induced Vascular Endothelial Cell EA.hy926 Injury. | Biomedicines | 2023 | 38002065 | PubTator, text mining | PubMed |
| MAP3K19 Affects TWEAK-Induced Response in Cultured Bronchial Epithelial Cells and Regulates Allergic Airway Inflammation in an Asthma Murine Model. | Curr Issues Mol Biol | 2023 | 37998736 | PubTator, text mining | PubMed |
| Unravelling the Role of Cancer Cell-Derived Extracellular Vesicles in Muscle Atrophy, Lipolysis, and Cancer-Associated Cachexia. | Cells | 2023 | 37998333 | PubTator, text mining | PubMed |
| A novel score of IL-13 and age predicts 90-day mortality in severe alcohol-associated hepatitis: A multicenter plasma biomarker analysis. | Hepatol Commun | 2023 | 37994498 | PubTator, text mining | PubMed |
| Dysregulations in hemostasis, metabolism, immune response, and angiogenesis in post-acute COVID-19 syndrome with and without postural orthostatic tachycardia syndrome: a multi-omic profiling study. | Sci Rep | 2023 | 37981644 | PubTator, text mining | PubMed |
| Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study. | Sci Rep | 2023 | 37973887 | PubTator, text mining | PubMed |
| SMIM20: a new biological signal associated with the prognosis of glioblastoma. | Transl Cancer Res | 2023 | 37969370 | PubTator, text mining | PubMed |
| Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients. | J Exp Clin Cancer Res | 2023 | 37957750 | PubTator, text mining | PubMed |
| Identification of immune-related candidate biomarkers in plasma of patients with sporadic vestibular schwannoma. | Sci Adv | 2023 | 37948527 | PubTator, text mining | PubMed |
| Cyanine Dye Conjugation Enhances Crizotinib Localization to Intracranial Tumors, Attenuating NF-κB-Inducing Kinase Activity and Glioma Progression. | Mol Pharm | 2023 | 37939020 | PubTator, text mining | PubMed |
| Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency. | Nature | 2023 | 37938781 | PubTator, text mining | PubMed |
| Muscle Inflammation Susceptibility: A Potential Phenotype for Guiding Precision Rehabilitation After Total Hip Arthroplasty in End-Stage Osteoarthritis. | HSS J | 2023 | 37937084 | PubTator, text mining | PubMed |
| Genetics and epidemiology of mutational barcode-defined clonal hematopoiesis. | Nat Genet | 2023 | 37932435 | PubTator, text mining | PubMed |
| Assessing serum cytokine profiles in inflammatory breast cancer patients using Luminex® technology. | Cytokine | 2023 | 37918053 | PubTator, text mining | PubMed |
| Cardiomyopathy in chronic kidney disease: clinical features, biomarkers and the contribution of murine models in understanding pathophysiology. | Clin Kidney J | 2023 | 37915935 | PubTator, text mining | PubMed |
| Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia. | J Cachexia Sarcopenia Muscle | 2023 | 37902006 | PubTator, text mining | PubMed |
| Crossroads between Autoimmunity and COVID-19 in Lung Transplant Recipients. | Viruses | 2023 | 37896822 | PubTator, text mining | PubMed |
| Lupus Nephritis in Children: Novel Perspectives. | Medicina (Kaunas) | 2023 | 37893559 | PubTator, text mining | PubMed |
| Update of Potential Biomarkers in Risk Prediction and Monitoring of Atherosclerosis in Systemic Lupus Erythematosus to Prevent Cardiovascular Disease. | Biomedicines | 2023 | 37893187 | PubTator, text mining | PubMed |
| TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors. | Biomedicines | 2023 | 37893178 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8742/papers?page=18